DNA/NN
Microarray/NN
Analysis/NN
of/IN
Gene/NN
Expression/NN
Profiles/NNS
in/IN
Aging/NN
process/NN
of/IN
Mouse/NN
Brain/NN
./.
====================
In/IN
order/NN
to/TO
investigate/VB
the/DT
molecular/JJ
basis/NN
of/IN
the/DT
aging/NN
process/NN
in/IN
brain/NN
,/,
we/PRP
have/VBP
employed/VBN
high-density/JJ
oligonucleotide/NN
microarrays/NNS
providing/VBG
data/NNS
on/IN
10,108/CD
gene/NN
clusters/NNS
to/TO
define/VB
transcriptional/JJ
patterns/NNS
in/IN
three/CD
brain/NN
regions/NNS
,/,
cerebral/JJ
cortex/NN
,/,
cerebellum/JJ
,/,
and/CC
hippocampus/NN
./.
====================
Comparison/NN
of/IN
the/DT
expression/NN
patterns/NNS
between/IN
young/JJ
(/(
6-week-old/JJ
)/)
and/CC
aged/JJ
(/(
17-month-old/JJ
)/)
C57BL/6/NN
male/JJ
micerevealed/JJ
that/DT
about/RB
ten/CD
percent/JJ
(/(
1098/CD
)/)
of/IN
the/DT
genes/NNS
showed/VBD
a/DT
significant/JJ
change/NN
in/IN
the/DT
expression/NN
level/NN
in/IN
at/IN
least/JJS
one/CD
of/IN
the/DT
three/CD
tissues/NNS
./.
====================
Among/IN
them/PRP
,/,
23/CD
genes/NNS
were/VBD
upregulated/VBN
and/CC
62/CD
genes/NNS
were/VBD
downregulated/VBN
in/IN
all/DT
three/CD
tissues/NNS
of/IN
the/DT
old/JJ
mice/NNS
./.
====================
The/DT
number/NN
of/IN
genes/NNS
upregulated/VBN
exclusively/RB
in/IN
hippocampus/NN
(/(
337/CD
)/)
was/VBD
much/RB
larger/JJR
compared/VBN
to/TO
other/JJ
tissues/NNS
./.
====================
Gene/NN
ontology-based/VBN
analysis/NN
showed/VBD
the/DT
genes/NNS
related/JJ
with/IN
signal/NN
transduction/NN
or/CC
molecular/JJ
transports/NNS
are/VBP
more/RBR
likely/JJ
to/TO
be/VB
upregulated/VBN
than/IN
downregulated/JJ
in/IN
the/DT
aging/NN
process/NN
of/IN
hippocampus/NN
./.
====================
These/DT
data/NNS
may/MD
provide/VB
some/DT
useful/JJ
means/NNS
for/IN
elucidating/VBG
the/DT
molecular/JJ
aspect/NN
of/IN
aging/NN
in/IN
hippocampus/NN
and/CC
other/JJ
regions/NNS
in/IN
brain/NN
./.
====================
With/IN
increased/VBD
life/NN
span/NN
resulting/VBG
from/IN
the/DT
improved/JJ
socioeconomic/JJ
status/NN
and/CC
the/DT
progress/NN
of/IN
medical/JJ
techniques/NNS
,/,
the/DT
aging/NN
process/NN
becomes/VBZ
one/CD
of/IN
the/DT
most/JJS
important/JJ
research/NN
subjects/NNS
in/IN
both/DT
social/JJ
and/CC
biomedical/JJ
sciences/VBZ
./.
====================
One/CD
of/IN
the/DT
major/JJ
problems/NNS
in/IN
the/DT
elderly/JJ
is/VBZ
the/DT
====================
cognitive/JJ
decline/NN
,/,
which/WDT
is/VBZ
related/JJ
with/IN
the/DT
aging/NN
process/NN
in/IN
the/DT
brain/NN
(/(
Yankner/NN
,/,
2000/CD
)/)
./.
====================
Despite/IN
a/DT
lot/JJ
of/IN
research/NN
,/,
themolecular/JJ
basis/NN
of/IN
brain/NN
aging/NN
still/RB
remains/VBZ
unclear/JJ
,/,
in/IN
part/NN
because/IN
we/PRP
lack/VBP
a/DT
large/JJ
number/NN
of/IN
biomarkers/NNS
for/IN
aging/NN
process/NN
in/IN
the/DT
brain/NN
./.
====================
DNA/NN
microarray/NN
technology/NN
is/VBZ
expected/VBN
to/TO
revolutionize/VB
the/DT
biomedical/JJ
research/NN
field/NN
through/IN
the/DT
simultaneous/JJ
analysis/NN
of/IN
gene/NN
expression/NN
patterns/NNS
in/IN
the/DT
whole/JJ
genome/NN
scale/NN
(/(
Lander/NN
,/,
1999/CD
)/)
./.
====================
There/EX
were/VBD
several/JJ
studies/NNS
about/IN
microarray/NN
analysis/NN
of/IN
the/DT
aged/JJ
brain/NN
in/IN
mouse/NN
,/,
rat/NN
,/,
or/CC
even/RB
human/JJ
(/(
Prolla/NN
,/,
2002/CD
;/:
Blalock/NN
et/FW
al/JJ
./.
,/,
2003/CD
;/:
Lu/NNP
et/FW
al/JJ
./.
,/,
2004/CD
;/:
Erraji-Benchekroun/NN
et/FW
al/JJ
./.
,/,
2005/CD
)/)
./.
====================
However/RB
,/,
analysis/NN
with/IN
only/RB
one/CD
region/NN
of/IN
the/DT
brain/NN
has/VBZ
a/DT
serious/JJ
limitation/NN
for/IN
the/DT
complete/JJ
understatingof/IN
the/DT
molecular/JJ
networks/NNS
involved/VBN
in/IN
the/DT
brain/NN
aging/NN
processes/NNS
,/,
which/WDT
are/VBP
enormously/RB
complex/NN
phenomena/NNS
related/JJ
with/IN
multiple/JJ
systems/NNS
,/,
cell/NN
types/NNS
,/,
and/CC
pathways/NNS
./.
====================
In/IN
addition/NN
,/,
recent/JJ
advances/NNS
in/IN
our/PRP$
information/NN
about/IN
the/DT
genome/NN
and/CC
development/NN
of/IN
the/DT
novel/JJ
technology/NN
like/IN
microarray/NN
can/MD
provide/VB
much/JJ
better/RBR
chance/NN
to/TO
identify/VB
significant/JJ
changes/NNS
in/IN
gene/NN
expression/NN
as/IN
compared/VBN
to/TO
a/DT
few/JJ
years/NNS
ago/RB
./.
====================
For/IN
that/DT
reason/NN
,/,
we/PRP
used/VBD
10K/CD
oligonucleotide/NN
microarray/NN
analysis/NN
for/IN
the/DT
simultaneous/JJ
investigation/NN
of/IN
gene/NN
expression/NN
changes/NNS
in/IN
cerebral/JJ
cortex/NN
,/,
cerebellum/NN
,/,
and/CC
hippocampus/NN
in/IN
young/JJ
and/CC
old/JJ
mice/NNS
./.
====================
Male/JJ
C57BL/6/NN
mice/NNS
were/VBD
purchased/VBN
at/IN
1.5/CD
months/NNS
of/IN
age/NN
from/IN
Polars/NNS
International/JJ
Corp./NNP
or/CC
obtained/VBN
at/IN
17/CD
months/NNS
of/IN
age/NN
from/IN
Silver/NN
Biotechnology/NN
Research/NN
Center/NN
of/IN
Hallym/JJ
University/NN
(/(
Korea/NN
)/)
./.
====================
Mice/NNS
were/VBD
sacrificed/VBN
by/IN
rapid/JJ
cervical/JJ
dislocation/NN
and/CC
brains/NNS
were/VBD
removed/VBN
./.
====================
For/IN
RNA/NN
extractions/NNS
,/,
the/DT
cerebral/JJ
cortex/NN
,/,
hippocampus/NN
,/,
and/CC
cerebellum/NN
were/VBD
dissected/VBN
and/CC
immediately/RB
frozen/VBN
in/IN
liquid/JJ
nitrogen/NN
and/CC
stored/VBD
at/IN
-80°C/NN
./.
====================
Total/JJ
RNA/NN
was/VBD
extracted/VBN
from/IN
the/DT
frozen/VBN
tissues/NNS
using/VBG
TRIZOL/NN
reagent/JJ
(/(
Life/NN
Technologies/NNS
,/,
USA/NNP
)/)
and/CC
a/DT
power/JJ
homogenizer/NN
(/(
Fisher/RB
Scientific/JJ
)/)
with/IN
the/DT
addition/NN
of/IN
chloroform/NN
for/IN
the/DT
phase/NN
separation/NN
before/IN
isopropyl/NN
alcohol/NN
precipitation/NN
oftotal/JJ
RNA/NN
./.
====================
RNA/NN
concentrations/NNS
====================
were/VBD
determined/VBN
spectrophotometrically/RB
and/CC
the/DT
quality/NN
of/IN
the/DT
isolated/VBN
RNA/NN
samples/NNS
was/VBD
assessed/VBN
using/VBG
gel/NN
electrophoresis/NN
./.
====================
Total/JJ
RNA/NN
(/(
5/CD
㎍/NN
)/)
was/VBD
converted/VBN
into/IN
double/JJ
stranded/JJ
cDNA/NN
using/VBG
the/DT
cDNA/NN
synthesis/NN
Sytem/NN
(/(
Roche/NNP
)/)
using/VBG
T7-/JJ
(/(
dT/NN
)/)
24/CD
primer/NN
./.
====================
The/DT
each/DT
cDNA/NN
was/VBD
purified/VBN
using/VBG
the/DT
RNeasy/NN
kit/NN
(/(
Qiagen/NN
;/:
Valencia/NN
,/,
USA/NN
)/)
./.
====================
Each/DT
Cy3-/NN
(/(
young/JJ
mice/NNS
brain/NN
)/)
,/,
or/CC
Cy5-/NN
(/(
old/JJ
mice/NNS
brain/NN
)/)
labeled/VBN
cRNA/NN
was/VBD
synthesized/VBN
using/VBG
the/DT
Megascript/NN
T7/NN
kit/NN
(/(
Ambion/NN
;/:
Austin/NN
,/,
USA/NNP
)/)
,/,
using/VBG
Cy3-CTP/NN
and/CC
Cy5-CTP/NN
(/(
APB//NN
Uppsala/FW
Sweden/JJ
)/)
./.
====================
The/DT
cRNA/NN
was/VBD
purified/VBN
using/VBG
the/DT
RNeasy/NN
./.
====================
15/CD
ug/NN
of/IN
each/DT
purified/VBN
cRNA/NN
was/VBD
mixed/VBN
and/CC
fragmented/JJ
in/IN
the/DT
fragmentation/NN
buffer/NN
(/(
40/CD
mM/NN
Tris/NN
,/,
pH/NN
8.1/CD
,/,
100/CD
mM/NN
KOAc/NN
,/,
and/CC
30/CD
mM/NN
MgOAC/NN
)/)
by/IN
heating/VBG
to/TO
94°C/NN
for/IN
15/CD
min/NN
./.
====================
The/DT
fragmented/JJ
cRNA/NN
was/VBD
mixed/VBN
with/IN
the/DT
hybridization/NN
MAGIC/NN
II-10K/NN
Oligo/JJ
Chip/NN
(/(
Macrogen/NN
;/:
Seoul/JJ
,/,
Korea/NN
)/)
for/IN
16/CD
h/NN
at/IN
42°C/NN
./.
====================
All/DT
preparations/NNS
met/NN
Macrogen/NN
's/POS
recommended/VBN
criteria/NNS
for/IN
use/NN
on/IN
their/PRP$
expression/NN
arrays/NNS
./.
====================
The/DT
arrays/NNS
were/VBD
then/RB
washed/VBD
and/CC
scanned/VBD
with/IN
the/DT
Array/NN
scanner/NN
(/(
APB/NN
)/)
./.
====================
Acquired/VBN
images/VBZ
were/VBD
processed/VBN
and/CC
analyzed/VBD
statistically/RB
for/IN
interpretation/NN
of/IN
analyzed/VBN
spot/NN
intensity/NN
results/NNS
using/VBG
Imagene/JJ
v4.1/NN
software/JJ
(/(
Roche/NNP
)/)
./.
====================
Nonbiological/JJ
factors/NNS
that/WDT
may/MD
contribute/VB
to/TO
variability/NN
of/IN
data/NNS
were/VBD
minimized/VBN
using/VBG
global/JJ
normalization/scaling/VBG
with/IN
data/NNS
from/IN
all/DT
probes/NNS
sets/NNS
./.
====================
Each/DT
chip/NN
contains/VBZ
a/DT
total/JJ
of/IN
10,368/CD
elements/NNS
of/IN
which/WDT
10,108/CD
are/VBP
unique/JJ
genes/clusters/NNS
./.
====================
The/DT
length/NN
of/IN
oligonucleotides/NNS
was/VBD
50-mer/JJ
./.
====================
For/IN
the/DT
cluster/NN
analysis/NN
,/,
total/JJ
1828/CD
genes/NNS
were/VBD
selected/VBN
by/IN
the/DT
criteria/NNS
of/IN
two-fold/JJ
change/NN
in/IN
at/IN
least/JJS
two/CD
different/JJ
samples/NNS
./.
====================
The/DT
software/JJ
packages/NNS
Cluster/NN
(/(
version/NN
2.11/CD
)/)
and/CC
TreeView/NN
(/(
version/NN
1.60/CD
)/)
were/VBD
downloaded/VBN
from/IN
the/DT
website/JJ
of/IN
Eisen/JJ
Lab/NN
(/(
http/NN
:/:
//rana.lbl.gov/EisenSoftware.htm/JJ
)/)
and/CC
used/VBN
for/IN
the/DT
cluster/NN
analysis/NN
and/CC
visualization/NN
./.
====================
The/DT
distance/NN
metric/JJ
based/VBN
upon/IN
uncentered/JJ
Pearson/NN
correlation/NN
was/VBD
used/VBN
for/IN
the/DT
hierarchical/JJ
clustering/NN
./.
====================
For/IN
tissue-specific/JJ
expression/NN
analysis/NN
,/,
the/DT
genes/NNS
that/WDT
showed/VBD
more/RBR
than/IN
2-fold/JJ
expression/NN
change/NN
in/IN
at/IN
least/JJS
two/CD
samples/NNS
from/IN
the/DT
same/JJ
type/NN
of/IN
tissues/NNS
were/VBD
selected/VBN
./.
====================
Each/DT
microarray/NN
data/NNS
was/VBD
sequentiallyprocessed/VBN
through/IN
global/JJ
normalization/NN
,/,
intensity-dependent/JJ
normalization/NN
,/,
and/CC
print-tip/NN
normalization/NN
./.
====================
Finally/RB
each/DT
of/IN
three/CD
data/NNS
from/IN
the/DT
same/JJ
tissue/NN
was/VBD
normalized/VBN
according/VBG
to/TO
the/DT
scale/NN
differences/NNS
of/IN
multiple/JJ
slides/NNS
./.
====================
Among/IN
the/DT
11,520/CD
probes/NNS
mounted/JJ
on/IN
the/DT
MAGIC/NN
II-10K/NN
Oligo/JJ
Chip/NN
,/,
we/PRP
selected/VBD
====================
1,828/CD
genes/NNS
that/WDT
showed/VBD
more/RBR
than/IN
two/CD
fold/JJ
difference/NN
in/IN
at/IN
least/JJS
two/CD
array/NN
data/NNS
sets/NNS
for/IN
the/DT
cluster/NN
analysis/NN
./.
====================
Hierarchical/JJ
clustering/NN
analysis/NN
revealed/VBD
that/IN
each/DT
set/NN
of/IN
arrays/NNS
from/IN
the/DT
same/JJ
tissue/NN
was/VBD
clustered/VBN
together/RB
except/IN
only/RB
in/IN
one/CD
sample/NN
,/,
cerebellum/NN
#/CD
1/CD
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
We/PRP
found/VBD
the/DT
similar/JJ
results/NNS
when/WRB
different/JJ
methods/NNS
such/JJ
as/IN
Spearman/JJ
Rank/NN
correlation/NN
or/CC
Kendall/JJ
's/POS
Tau/NN
method/NN
were/VBD
applied/VBN
for/IN
the/DT
cluster/NN
analysis/NN
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
A/DT
different/JJ
pattern/NN
of/IN
gene/NN
expression/NN
in/IN
cerebellum/NN
#/CD
1/CD
sample/NN
was/VBD
so/RB
obvious/JJ
that/DT
we/PRP
concluded/VBD
to/TO
exclude/VB
this/DT
sample/NN
for/IN
further/JJ
analysis/NN
====================
Then/RB
,/,
we/PRP
further/RB
selected/VBN
the/DT
gene/NN
sets/NNS
that/DT
showed/VBD
the/DT
same/JJ
pattern/NN
of/IN
expression/NN
in/IN
the/DT
same/JJ
tissue/NN
./.
====================
Total/JJ
1,098/CD
genes/NNS
showed/VBD
more/RBR
than/IN
two/CD
fold/JJ
upregulation/NN
or/CC
downregulation/NN
in/IN
at/IN
least/JJS
twoarray/RB
experiments/NNS
from/IN
the/DT
same/JJ
tissue/NN
./.
====================
Table/JJ
1/CD
shows/VBZ
the/DT
classification/NN
of/IN
1,098/CD
genes/NNS
according/VBG
to/TO
the/DT
pattern/NN
of/IN
expression/NN
changes/NNS
./.
====================
Interestingly/RB
,/,
nine/CD
genes/NNS
showed/VBD
a/DT
different/JJ
pattern/NN
of/IN
expression/NN
changes/NNS
in/IN
different/JJ
tissues/NNS
,/,
that/DT
is/VBZ
,/,
upregulation/NN
in/IN
one/CD
tissue/NN
,/,
but/CC
downregulation/NN
in/IN
another/DT
tissue/NN
./.
====================
That/DT
is/VBZ
the/DT
reason/NN
why/WRB
the/DT
sum/NN
of/IN
upregulated/VBN
genes/NNS
(/(
656/CD
)/)
and/CC
downregulated/VBD
genes/NNS
(/(
451/CD
)/)
is/VBZ
greater/JJR
than/IN
1,098/CD
./.
====================
Table/JJ
1/CD
also/RB
shows/VBZ
that/IN
the/DT
number/NN
of/IN
genes/NNS
upregulated/VBN
or/CC
downregulated/JJ
in/IN
cerebellum/NN
is/VBZ
much/RB
less/RBR
than/IN
in/IN
other/JJ
tissues/NNS
./.
====================
This/DT
may/MD
be/VB
due/JJ
to/TO
the/DT
exclusion/NN
of/IN
one/CD
sample/NN
from/IN
the/DT
cerebellum/NN
data/NNS
set/VBP
,/,
which/WDT
reduces/VBZ
the/DT
number/NN
of/IN
array/NN
experiments/NNS
to/TO
only/RB
two/CD
./.
====================
One/CD
interesting/VBG
point/NN
from/IN
the/DT
table/JJ
1/CD
is/VBZ
the/DT
number/NN
of/IN
upregulated/VBN
genes/NNS
in/IN
hippocampus.Upregulated/JJ
genes/NNS
in/IN
cerebral/JJ
cortex/NN
(/(
244/CD
total/JJ
,/,
and/CC
134/CD
exclusive/JJ
)/)
,/,
downregulated/VBD
genes/NNS
in/IN
cerebral/JJ
cortex/NN
(/(
266/CD
total/JJ
,/,
and/CC
133/CD
exclusive/JJ
)/)
,/,
and/CC
downregulated/VBD
genes/NNS
in/IN
hippocampus/FW
(/(
252/CD
total/JJ
,/,
137/CD
exclusive/JJ
)/)
showed/VBD
a/DT
quite/RB
similar/JJ
pattern/NN
of/IN
expression/NN
changes/NNS
./.
====================
However/RB
,/,
the/DT
number/NN
of/IN
genes/NNS
upregulated/VBN
exclusively/RB
in/IN
hippocampus/NN
(/(
337/CD
)/)
was/VBD
much/RB
larger/JJR
than/IN
in/IN
other/JJ
tissues/NNS
./.
====================
It/PRP
suggests/VBZ
that/IN
the/DT
gene/NN
expression/NN
change/NN
(/(
especially/RB
upregulation/NN
)/)
occurs/VBZ
predominantly/RB
in/IN
hippocampus/NN
,/,
which/WDT
may/MD
be/VB
related/JJ
to/TO
the/DT
characteristic/JJ
cognitive/JJ
changes/NNS
in/IN
the/DT
aging/NN
process/NN
./.
====================
Table/JJ
2/CD
,/,
3/CD
and/CC
4/CD
show/VBP
the/DT
top-ranked/JJ
twenty/JJ
genes/NNS
that/WDT
are/VBP
upregulated/VBN
or/CC
downregulated/JJ
in/IN
each/DT
of/IN
three/CD
tissues/NNS
./.
====================
One/CD
of/IN
the/DT
notable/JJ
findings/NNS
in/IN
these/DT
tables/NNS
was/VBD
====================
that/DT
a/DT
member/NN
of/IN
protocadherin-gamma/NN
subfamily/NN
B/NN
showed/VBD
the/DT
most/JJS
dramatic/JJ
decrease/NN
in/IN
the/DT
expression/NN
in/IN
all/DT
three/CD
tissues/NNS
./.
====================
Cadherins/NNS
are/VBP
calcium-dependent/JJ
cell-cell/JJ
adhesion/NN
molecules/NNS
that/WDT
mediate/VBP
neural/JJ
cell-cell/JJ
interactions/NNS
,/,
and/CC
protocadherins/NNS
(/(
pcdh/NN
)/)
constitute/VBP
a/DT
subfamily/NN
of/IN
nonclassic/JJ
cadherins/NNS
./.
====================
The/DT
pcdh/JJ
gene/NN
clusters/NNS
are/VBP
known/VBN
to/TO
have/VB
very/RB
similar/JJ
genomic/JJ
architecture/NN
with/IN
the/DT
immunoglobulin/NN
and/CC
T/NN
cell/NN
receptor/NN
gene/NN
clusters/NNS
,/,
and/CC
can/MD
potentially/RB
provide/VBP
a/DT
significant/JJ
molecular/JJ
diversity/NN
like/IN
them/PRP
(/(
Wang/NNP
et/FW
al/JJ
./.
,/,
2002/CD
)/)
./.
====================
Pcdh/DT
genes/NNS
are/VBP
present/JJ
in/IN
most/JJS
neurons/NNS
,/,
and/CC
are/VBP
the/DT
primary/JJ
candidates/NNS
for/IN
synapse/NN
formation/NN
and/CC
cell/NN
survival/NN
during/IN
development/NN
(/(
Weiner/NN
et/FW
al/JJ
./.
,/,
2005/CD
;/:
Junghans/NNS
et/FW
al/JJ
./.
,/,
2005/CD
)/)
./.
====================
The/DT
dramatic/JJ
change/NN
in/IN
the/DT
expression/NN
level/NN
of/IN
one/CD
member/NN
of/IN
the/DT
pcdh-gamma/NN
families/NNS
suggests/VBZ
the/DT
possible/JJ
role/NN
of/IN
this/DT
gene/NN
product/NN
in/IN
the/DT
age-related/JJ
changes/NNS
in/IN
the/DT
synapse/NN
and/CC
neuronal/JJ
architectures/NNS
./.
====================
Among/IN
the/DT
upregulated/VBN
genes/NNS
,/,
grb2-related/VBN
adaptor/NN
protein/NN
2/CD
(/(
grap2/NN
)/)
,/,
lipocalin/NN
2/CD
,/,
cystatin/NN
7/CD
(/(
cystatin/NN
F/NN
)/)
,/,
sushi-repeat-containing/VBG
protein/NN
(/(
srpx/NN
,/,
or/CC
drs/VBZ
)/)
,/,
and/CC
matrix/NN
metallopeptidase/NN
1b/NN
were/VBD
prominent/JJ
./.
====================
There/EX
are/VBP
some/DT
reports/NNS
about/RB
the/DT
roles/NNS
of/IN
these/DT
gene/NN
products/NNS
in/IN
hematopoietic/JJ
cells/NNS
(/(
Ludwig/NN
et/FW
al/JJ
./.
,/,
2003/CD
;/:
Flo/NN
et/FW
al/JJ
./.
,/,
2004/CD
;/:
Nathason/NNP
et/FW
al/JJ
./.
,/,
2002/CD
)/)
,/,
carcinogenesis/NN
(/(
Hanai/NNP
et/FW
al/JJ
./.
,/,
2005/CD
;/:
Yamashita/NNP
et/FW
al/JJ
./.
,/,
1999/CD
)/)
,/,
or/CC
other/JJ
disorders/NNS
(/(
Meindl/NNP
et/FW
al/JJ
./.
,/,
1995/CD
)/)
./.
====================
However/RB
,/,
the/DT
distinct/JJ
role/NN
of/IN
these/DT
genes/NNS
in/IN
brain/NN
or/CC
senescence/NN
is/VBZ
largely/RB
unknown/JJ
./.
====================
One/CD
exception/NN
is/VBZ
the/DT
report/NN
from/IN
MacManus/NN
et/FW
al/JJ
./.
====================
(/(
2005/CD
)/)
that/WDT
showed/VBD
the/DT
upregulation/NN
of/IN
lipocalin/NN
2/CD
in/IN
mouse/NN
brain/NN
after/IN
focal/JJ
ischemia/NN
./.
====================
Itsuggests/NNS
that/DT
these/DT
genes/NNS
have/VBP
very/RB
restricted/JJ
roles/NNS
in/IN
normal/JJ
brain/NN
,/,
but/CC
may/MD
be/VB
related/JJ
to/TO
aging/VBG
process/NN
itself/PRP
or/CC
aging-related/JJ
phenotypes/NNS
in/IN
some/DT
part/NN
of/IN
the/DT
nervous/JJ
system/NN
./.
====================
Table/JJ
5/CD
and/CC
6/CD
show/VBP
the/DT
list/NN
of/IN
genes/NNS
up-/RB
or/CC
down-regulated/VBN
in/IN
tissue/NN
specific/JJ
manners/NNS
./.
====================
We/PRP
believe/VBP
that/IN
this/DT
type/NN
of/IN
analysis/NN
would/MD
be/VB
more/RBR
efficient/JJ
in/IN
estimating/VBG
the/DT
role/NN
of/IN
possible/JJ
target/NN
genes/NNS
in/IN
aging/VBG
process/NN
./.
====================
For/IN
example/NN
,/,
laminin/NN
alpha/NN
1/CD
was/VBD
downregulated/VBN
significantly/RB
in/IN
all/DT
three/CD
tissues/NNS
although/IN
it/PRP
could/MD
not/RB
be/VB
easily/RB
foundin/NN
the/DT
list/NN
of/IN
top-ranked/JJ
downregulated/VBD
genes/NNS
./.
====================
Laminin/NN
is/VBZ
a/DT
basement/JJ
membrane/NN
protein/NN
,/,
and/CC
a/DT
variety/NN
of/IN
different/JJ
laminins/NNS
can/MD
be/VB
found/VBN
in/IN
the/DT
vascular/JJ
basement/JJ
membrane/NN
of/IN
the/DT
adult/JJ
and/CC
aged/JJ
brain/NN
(/(
Jucker/NN
et/FW
al/JJ
./.
,/,
1996/CD
)/)
./.
====================
Laminin/NN
alpha/NN
1/CD
has/VBZ
been/VBN
found/VBN
to/TO
be/VB
overexpressed/VBN
in/IN
Alzheimer/NN
's/POS
disease/NN
frontal/JJ
cortex/NN
,/,
and/CC
localized/VBD
to/TO
reactive/JJ
astrocytes/NNS
of/IN
the/DT
gray/JJ
and/CC
white/JJ
matter/NN
,/,
and/CC
as/IN
punctate/JJ
deposits/VBZ
in/IN
the/DT
senile/JJ
plaques/NNS
of/IN
the/DT
Alzheimer/NN
's/POS
brain/NN
tissue/NN
(/(
Palu/NN
et/FW
al/JJ
./.
,/,
2002/CD
)/)
./.
====================
On/IN
the/DT
contrary/NN
,/,
Morita/NNP
et/FW
al/JJ
./.
====================
(/(
2005/CD
)/)
reported/VBD
a/DT
decrease/NN
in/IN
laminin/NN
immunolabeling/NN
in/IN
the/DT
capillary/JJ
basement/JJ
membranes/NNS
of/IN
old/JJ
dogs/NNS
./.
====================
The/DT
investigation/NN
of/IN
correlation/NN
between/IN
the/DT
heterogeneity/NN
of/IN
laminin/NN
expression/NN
and/CC
the/DT
structural/JJ
and/CC
functional/JJ
====================
diversity/NN
of/IN
the/DT
vascular/JJ
basement/JJ
membranes/NNS
in/IN
aging/NN
process/NN
would/MD
be/VB
an/DT
interesting/JJ
topic/JJ
in/IN
this/DT
field/NN
./.
====================
The/DT
genes/NNS
up-/RB
or/CC
down-regulated/VBN
in/IN
only/RB
one/CD
tissue/NN
,/,
especially/RB
in/IN
hippocampus/NN
,/,
would/MD
be/VB
attractive/JJ
targets/NNS
====================
for/IN
research/NN
about/IN
cognitive/JJ
changes/NNS
in/IN
the/DT
aging/NN
process/NN
./.
====================
Transthyretin/NN
(/(
also/RB
known/VBN
as/IN
prealbumin/NN
)/)
,/,
the/DT
major/JJ
transporter/NN
of/IN
thyroid/NN
hormones/NNS
was/VBD
one/CD
of/IN
the/DT
most/JJS
highly/RB
upregulated/VBN
genes/NNS
in/IN
hippocampus/NN
(/(
Table/JJ
====================
5/CD
)/)
./.
====================
Transthyretin/NN
has/VBZ
been/VBN
well/RB
known/VBN
to/TO
bind/VB
the/DT
Alzheimer/NN
beta-peptide/IN
and/CC
to/TO
be/VB
a/DT
possible/JJ
protector/NN
against/IN
neurodegeneration/NN
./.
====================
Recent/JJ
findings/NNS
suggest/VBP
new/JJ
roles/NNS
of/IN
this/DT
protein/NN
related/JJ
with/IN
depression-like/JJ
behavior/NN
or/CC
other/JJ
psychiatric/JJ
disorders/NNS
(/(
Sousa/NN
et/FW
al/JJ
./.
,/,
2004/CD
)/)
./.
====================
cAMP/NN
responsive/JJ
element/NN
binding/NN
protein/NN
1/CD
(/(
CREB1/NN
)/)
is/VBZ
included/VBN
in/IN
the/DT
list/NN
of/IN
genes/NNS
exclusively/RB
downregulated/VBN
in/IN
hippocampus/NN
(/(
Table/JJ
6/CD
)/)
./.
====================
The/DT
role/NN
of/IN
CREB1/NN
in/IN
long-term/JJ
memory/NN
formation/NN
in/IN
hippocampus/NN
is/VBZ
already/RB
well/RB
known/VBN
,/,
and/CC
a/DT
number/NN
of/IN
reports/NNS
showed/VBD
that/IN
the/DT
change/NN
of/IN
this/DT
protein/NN
is/VBZ
closely/RB
related/JJ
to/TO
the/DT
memory/NN
====================
dysfunction/NN
in/IN
the/DT
aging/NN
process/NN
(/(
Kudo/NN
et/FW
al/JJ
./.
,/,
2005/CD
;/:
Monti/NNP
et/FW
al/JJ
./.
,/,
2005/CD
;/:
Brightwell/JJ
et/FW
al/JJ
./.
,/,
2004/CD
)/)
./.
====================
This/DT
would/MD
be/VB
another/DT
example/NN
providing/VBG
the/DT
reliability/NN
of/IN
our/PRP$
study/NN
results/VBZ
./.
====================
Finally/RB
we/PRP
tried/VBD
to/TO
analyze/VB
the/DT
distribution/NN
of/IN
up-/RB
or/CC
down-regulated/VBN
genes/NNS
according/VBG
to/TO
the/DT
gene/NN
ontology/NN
====================
classification/NN
that/DT
was/VBD
provided/VBN
by/IN
the/DT
microarray/NN
company/JJ
,/,
Macrogen/NN
./.
====================
Although/IN
most/JJS
of/IN
the/DT
gene/NN
ontology/NN
classes/NNS
had/VBD
similar/JJ
distribution/NN
of/IN
up-/RB
and/CC
down-/NN
regulated/VBN
genes/NNS
,/,
some/DT
of/IN
them/PRP
showed/VBD
interesting/JJ
patterns/NNS
(/(
Table/JJ
7/CD
)/)
./.
====================
For/IN
example/NN
,/,
the/DT
genes/NNS
involved/VBN
in/IN
G-protein/NN
coupled/VBN
receptor/NN
protein/NN
signaling/NN
pathways/NNS
====================
have/VBP
a/DT
dominance/NN
of/IN
upregulation/NN
in/IN
hippocampus/NN
and/CC
downregulation/NN
in/IN
cerebellum/NN
./.
====================
Similarly/RB
,/,
the/DT
genes/NNS
classified/VBN
as/IN
small/JJ
GTPase/NN
mediated/VBN
signal/NN
transduction/NN
were/VBD
more/RBR
upregulated/VBN
than/IN
downregulated/JJ
in/IN
hippocampus/NN
./.
====================
The/DT
meaning/JJ
of/IN
these/DT
findings/NNS
can/MD
not/RB
be/VB
easily/RB
explained/VBN
./.
====================
However/RB
,/,
with/IN
the/DT
findingthat/JJ
more/RBR
genes/NNS
are/VBP
upregulated/VBN
in/IN
hippocampus/FW
than/IN
in/IN
other/JJ
tissues/NNS
(/(
Table/JJ
1/CD
)/)
and/CC
several/JJ
classes/NNS
related/JJ
with/IN
signaling/VBG
or/CC
transport/VBP
have/VBP
tendency/NN
of/IN
upregulation/NN
in/IN
hippocampus/FW
(/(
Table/JJ
7/CD
)/)
,/,
we/PRP
can/MD
suggest/VBP
that/IN
the/DT
senescence/NN
in/IN
hippocampus/FW
may/MD
be/VB
linked/VBN
to/TO
gain/VB
of/IN
function/NN
related/JJ
with/IN
active/JJ
signal/NN
transduction/NN
rather/RB
than/IN
just/RB
passive/JJ
changes/NNS
of/IN
dysfunction/NN
./.
====================
We/PRP
believe/VBP
that/IN
a/DT
lot/JJ
of/IN
investigations/NNS
are/VBP
still/RB
required/VBD
in/IN
this/DT
area/NN
,/,
and/CC
our/PRP$
result/NN
may/MD
provide/VB
some/DT
useful/JJ
tools/NNS
for/IN
studying/VBG
the/DT
molecular/JJ
aspect/NN
of/IN
aging/VBG
in/IN
the/DT
brain/NN
./.
====================
